Abbott To Develop New Heart Failure Test On ARCHITECT® Immunochemistry Diagnostics Platform
Abbott (NYSE: ABT) and BG Medicine, Inc. announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott’s ARCHITECT immunochemistry instrument platform, specifically the company’s i1000SR and i2000SR instruments.
Go to Source
People who read this also read
- Dilon Diagnostics Gamma-Guided Localization System Cleared By FDA
Dilon Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance. GammaLoc(®), pronoun... - End Of H1N1 ‘Second Wave’ In Sight In The U.S., According To Quest Diagnostics
Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the "second wave" of virus infection that sickened tens of m... - At Five-Year Milestone, InHealth Assesses Progress Toward Understanding The Impact Of Medical Devices And Diagnostics
As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the rol... - Scientists Gain New Understanding Of Disease-Causing Bacteria
A team of scientists from The Forsyth Institute, the University of Connecticut Health Center, the CDC and the Wadsworth Center, have used state-of-the-art technology to elucidate the molecular archite... - BSGI Makes Significant Impact On Detection Of Breast Cancer In Patients With Negative Mammographic Findings
Breast-Specific Gamma Imaging (BSGI) significantly contributes to the detection of malignant or high-risk lesions in patients with negative or indeterminate mammographic findings, according to results... - Alzheimer’s Researcher Joins UF To Fight Brain Disease
A leader in the fight against brain diseases and in drug discovery to help Alzheimer's patients has joined the University of Florida College of Medicine, interim dean Michael Good, M.D., announced. T... - Improved Communication For Rescue Workers
For rescuers working in remote places, working phones and internet are literally a question of life and death. A team of researchers and businesses in Norway, Spain and Finland decided they need to be... - Famed 101-year-old Brazilian architect Oscar Niemeyer back at work following surgery
Reports: 101-yr-old Brazil architect back at work
BRASILIA, Brazil — Famed 101-year-old Brazilian architect Oscar Niemeyer is reportedly back at work just weeks after surgery for gallstones and an in...
